Gadolinum Deposition and the Safety of MRI Contrast Agents

May 20th, 2016Dec 31st, 1969
Washington, DC, DC
US
Phone:607-257-5860, ext. 29
A 45-minute panel discussion on recent findings of gadolinium deposition in patients who have undergone contrast-enhanced MRI. Being held May 21 at noon in the Grand Ballroom, as part of the America Society of Neuroradiology annual meeting.
Page 1 of 69
Next Page